Actively Recruiting
PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-08-09
900
Participants Needed
2
Research Sites
79 weeks
Total Duration
On this page
Sponsors
A
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead Sponsor
A
AstraZeneca
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective cohort study, where the investigators aim to investigate the effect of implementation of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological classes for the treatment of patients with heart failure and reduced ejection fraction (HFrEF) at the outpatient clinic in the Netherlands.
CONDITIONS
Official Title
PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Treatment for HFrEF at the outpatient clinic cardiology
- Documented reduced ejection fraction of <40% based on cardiac ultrasound or cardiac magnetic resonance imaging
You will not qualify if you...
- Opt-out for the use of routine clinical data for research purposes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Amsterdam University Medical Centers, Location AMC
Amsterdam, Netherlands
Actively Recruiting
2
Amsterdam University Medical Centers, Location VU Medical Center
Amsterdam, Netherlands
Actively Recruiting
Research Team
F
Folkert Assselbergs, MD PhD
CONTACT
A
A Uijl
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here